Finding protein markers that show how exercise helps heart failure patients
Identifying Proteomic Markers of Exercise Training in Heart Failure
This study is looking at how exercise can help people with heart failure by checking for changes in certain proteins in their blood before and after they start an exercise program, so we can find better ways to help them feel better and recover.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11042809 on NIH RePORTER |
What this research studies
This research investigates how exercise training can improve the health of patients with heart failure by identifying specific proteins in the blood that change with exercise. The study will use advanced proteomic profiling techniques to analyze blood samples from heart failure patients before and after they undergo exercise training. By comparing these results with healthy adults, the researchers aim to understand the molecular changes that occur in response to exercise, which could lead to better rehabilitation strategies for heart failure patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with heart failure.
Not a fit: Patients with heart failure who are unable to participate in exercise training due to severe comorbidities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved exercise rehabilitation programs that enhance the quality of life for heart failure patients.
How similar studies have performed: Previous research has shown promising results in understanding the molecular effects of exercise in other populations, suggesting that this approach may yield valuable insights for heart failure patients as well.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Katz, Daniel Hunter — Stanford University
- Study coordinator: Katz, Daniel Hunter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.